التفاصيل البيبلوغرافية
| العنوان: |
Supplementary Figure 3 from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma |
| المؤلفون: |
Ghassan K. Abou-Alfa, Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Priya Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H. Schwartz, Anthony B. El-Khoueiry, Jennifer J. Knox, Lakshmi Rajdev, Monica M. Bertagnolli, Jeffrey A. Meyerhardt, Eileen M. O'Reilly, Alan P. Venook |
| سنة النشر: |
2024 |
| مصطلحات موضوعية: |
Cancer, Therapeutic Research and Development, Clinical Research and Trials, Gastrointestinal Cancers, Liver cancer, Translational Research, Small Molecule Agents, Kinase inhibitors, Topoisomerase agents, DNA-reactive agents, Chemotherapy, Combination chemotherapy, Clinical-Stage Research, Clinical Trial Results, Phase III clinical trials |
| الوصف: |
Supplementary Figure 3. Kaplan-Meier curves for the progression-free survival distributions for patients who have detectable (HCV-D) vs. undetectable (HCV-UN) HCV titer levels on their first evaluated sample, by treatment arm. |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
unknown |
| العلاقة: |
https://figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_CALGB_80802_Alliance_Impact_of_Sorafenib_with_and_without_Doxorubicin_on_Hepatitis_C_Infection_in_Patients_with_Advanced_Hepatocellular_Carcinoma/25359909Test |
| DOI: |
10.1158/2767-9764.25359909.v1 |
| الإتاحة: |
https://doi.org/10.1158/2767-9764.25359909.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_CALGB_80802_Alliance_Impact_of_Sorafenib_with_and_without_Doxorubicin_on_Hepatitis_C_Infection_in_Patients_with_Advanced_Hepatocellular_Carcinoma/25359909Test |
| حقوق: |
CC BY |
| رقم الانضمام: |
edsbas.9F8CBF3F |
| قاعدة البيانات: |
BASE |
